SpineEx filed to raise up to $17 million in an initial public offering Sept. 18, Renaissance Capital reports.
Here are three things to know:
1. SpineEx develops implants for spinal fusion surgery.
2. ThinkEquity is the deal's only bookrunner.
3. Pricing terms were not disclosed.